NCT00210912View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

PHASE3CompletedINTERVENTIONAL

Enrollment

328

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

April 30, 2005

Conditions

Migraine

Interventions

DRUG

topiramate

All Listed Sponsors

collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210912 - A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches | Biotech Hunter | Biotech Hunter